Novel molecules, a recently identified group of bactericidal agents, provide a exciting frontier in the persistent battle against ever-more resistant microbes. Preliminary research indicate that these engineered sequences exhibit diverse activity against various difficult species, like ones immune to conventional antibiotics. Further research is cu